Aric Christal, MD
Adult Reconstructive Orthopaedic Surgery · Edmonds, WANPI 1770699159
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (59.1%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 85.4% of it on its own, with 10 other manufacturers making up the rest.
Across 327 payments — averaging $671.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$188K
- Avanos Medical$30K
- Pacira Pharmaceuticals Incorporated$2K
- Ferring Pharmaceuticals Inc.$345
- Johnson & Johnson$105
- Zimmer Biomet$80
- plus $193 from 5 others
Across 1 payment — averaging $2600.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Avanos Medical$3K
What the payments were for
- Consulting fees$53,08024%
- Speaking & faculty fees$129,96359%
- Travel & lodging$26,52812%
- Food & beverage$10,1545%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 266 | $187,712 |
| Avanos Medical | 29 | $29,706 |
| Pacira Pharmaceuticals Incorporated | 5 | $1,583 |
| Ferring Pharmaceuticals Inc. | 17 | $345 |
| Johnson & Johnson | 3 | $105 |
| Zimmer Biomet | 1 | $80 |
| Stryker | 2 | $66 |
| Medacta USA, Inc. | 1 | $59 |
| Pfizer | 1 | $31 |
| Vertex | 1 | $19 |
| Orthofix Medical, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Journey II$186,153
- REAL INTELLIGENCE$141,547
- Legion Revision$33,168
- ON-Q$29,007
- Tandem$25,279
- OR3O Dual Mobility$20,636
- RI.HIP NAVIGATION$20,139
- POLARSTEM$19,970
- Journey II BCS$19,022
- JOURNEY$15,578
- Journey II CR$15,201
- K-15 PORK$13,125
- PICO$10,995
- CORI$9,415
- Engage Partial Knee System$9,358
- JOURNEY II UK$8,733
- POLARCUP$8,630
- Anthology$7,460
- PICO 7$7,245
- Legion$6,349
How this compares
Too few adult reconstructive orthopaedic surgery providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $6,082 |
| Mupirocin | 137 | $1,063 |
| Oxycodone Hcl | 167 | $968 |
| Meloxicam | 153 | $710 |
| Ondansetron Hcl | 137 | $691 |
| Cephalexin | 131 | $346 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $287 |
| Celecoxib | 16 | $240 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 107 | $187 |
| Amoxicillin | 153 | $153 |
| Famotidine | 16 | $94 |
| Clindamycin Hcl | 32 | $49 |
| Hydromorphone Hcl | 11 | $34 |
| Tramadol Hcl | 11 | $16 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $31 | $6,08214 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few adult reconstructive orthopaedic surgery providers in Washingtonon file to place this against a meaningful peer group, so we don't.
Other adult reconstructive orthopaedic surgery in Edmonds
- David ScottSpokane$671K
- Jason HsuSeattle$287K
- Alexander ReichardSpokane$49K
- Nicholas HernandezSeattle$32K
- Cameron EganSeattle$17K
- Jacob StanfieldRichland$14K
- Joseph DannenbaumTacoma$12K
- Patrick MaherKirkland$10K
- Ronald QuamEverett$7K
- Elyse BrinkmannSeattle$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.